How big is the Asia Pacific In Vitro Diagnostics Market?

February 2023: Mylab Discovery Solutions announced it is all set to roll out new in vitro diagnostic (IVD) medical devices and kits to empower small labs in India.
February 2022: Mylab Discovery Solutions launched CoviSwift, a point-of-care (POC) testing solution comprising the CoviSwift assay and Compact-Q machines and process 16 samples within 40 minutes, four times faster than the typical RT-PCR testing procedure.

The Asia Pacific In Vitro Diagnostics Market size is expected to reach USD 24.21 billion in 2024 and grow at a CAGR of 5.70% to reach USD 31.94 billion by 2029. Read More

What is the current Asia Pacific In Vitro Diagnostics Market size?

In 2024, the Asia Pacific In Vitro Diagnostics Market size is expected to reach USD 24.21 billion. Read More

Who are the key players in Asia Pacific In Vitro Diagnostics Market?

Abbott, Siemens Healthineers AG, bioMérieux SA, Thermo Fisher Scientific and F Hoffmann-La Roche Ltd are the major companies operating in the Asia Pacific In Vitro Diagnostics Market. Read More

What years does this Asia Pacific In Vitro Diagnostics Market cover, and what was the market size in 2023?

In 2023, the Asia Pacific In Vitro Diagnostics Market size was estimated at USD 22.83 billion. The report covers the Asia Pacific In Vitro Diagnostics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Asia Pacific In Vitro Diagnostics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Asia Pacific In Vitro DiagnosticsCompanies

This report lists the top Asia Pacific In Vitro Diagnostics companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Asia Pacific In Vitro Diagnostics industry.